Skip to main content
. 2023 Mar 10;15(3):910. doi: 10.3390/pharmaceutics15030910

Table 1.

Summary of prepared bacterial batches (abbreviation; composition of batches).

Abbreviation of Prepared Batch 1 Components of Batches 2
Constitutional Excipient Cryoprotectant Bacterial Culture
LP_US2_IN Neusilin® US2 Inulin Lactobacillus plantarum R2 Biocenol™
LP_US2_SA Saccharose
LP_US2_ST Starch 1500®
LP_NS2N_IN Neusilin® NS2N Inulin
LP_NS2N_SA Saccharose
LP_NS2N-ST Starch 1500®
LP_AV_IN Avicel® PH-101 Inulin
LP_AV_SA Saccharose
LP_AV_ST Starch 1500®
LP_IN Inulin
LP_SA Saccharose
LP_ST Starch 1500®
LP_US2 Neusilin® US2
LP_NS2N Neusilin® NS2N
LP_AV Avicel® PH-101
LP

1 Abbreviation of each sample was established by the presence of Lactobacillus plantarum R2 Biocenol™ bacterial culture (LP); constitutional excipient (Neusilin® US2 (US2); Neusilin® NS2N (NS2N); Avicel® PH-101 (AV)); and cryoprotectant employed (inulin (IN); saccharose (SA); starch 1500® (ST)). 2 Each batch consisted of quadruple samples (weighing 20.0 g per sample). Components (bacterial culture: constitutional excipient: cryoprotectant) were always prepared in the preserved ratio of 8:1:1.